PP
KIN

PDT Partners’s Kindred Biosciences, Inc. KIN Stock Holding History

PDT Partners’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-22,400
Closed -$205K – 981
2021
Q2 		$205K Sell
22,400
-19,353
-46% -$113K 0.01% 699
2021
Q1 		$208K Buy
41,753
+7,653
+22% +$37K 0.01% 696
2020
Q4 		$147K Sell
34,100
-5,050
-13% -$20.5K 0.01% 638
2020
Q3 		$168K Buy
39,150
+27,789
+245% +$116K 0.01% 648
2020
Q2 		$51K Buy
+11,361
New +$50.8K ﹤0.01% 649
2018
Q3 		– Sell
-22,199
Closed -$236K – 558
2018
Q2 		$236K Sell
22,199
-7,500
-25% -$73.1K 0.01% 459
2018
Q1 		$257K Sell
29,699
-300
-1% -$2.63K 0.01% 504
2017
Q4 		$283K Sell
29,999
-17,600
-37% -$138K 0.01% 485
2017
Q3 		$374K Buy
47,599
+18,099
+61% +$136K 0.01% 460
2017
Q2 		$254K Buy
+29,500
New +$212K 0.01% 465
2014
Q2 		– Sell
-11,694
Closed -$217K – 1727
2014
Q1 		$217K Buy
+11,694
New +$223K 0.01% 1217

Other funds holding KIN

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

PDT Partners's KIN Position: Q3 2021 in Review

PDT Partners sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 22,400 shares — an estimated $205K sold.

PDT Partners first reported a position in KIN in Q1 2014 and held it in 11 quarters. The position peaked at $374K in Q3 2017. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

  • PDT Partners reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • PDT Partners sold 22,400 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $205K.
  • PDT Partners first reported a position in Kindred Biosciences, Inc. in Q1 2014 and held it in 11 quarters.
  • PDT Partners's Kindred Biosciences, Inc. position peaked at $374K in Q3 2017.
  • 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on PDT Partners's 13F filing for Q3 2021, filed 15 Nov 2021.